- Participants will undergo pre-treatment and progression tumor biopsies. Participants will also undergo pre-treatment and progression tumor biopsies for assessment of possible mechanisms of AA resistance. After the progression biopsy is performed, protocol therapy will be discontinued. Participants who stop protocol therapy before receiving four cycles of AA will not be asked to undergo the second biopsy.